Brief: Evofem Biosciences Announces Record Net Sales And Phexxi Prescriptions In Q4 2021

Evofem Biosciences

19/01/2022 14:18

Jan 19 (Reuters) - Evofem Biosciences Inc  EVFM.O :
    * EVOFEM BIOSCIENCES ANNOUNCES RECORD NET SALES AND PHEXXI
PRESCRIPTIONS IN Q4 2021
    * EVOFEM BIOSCIENCES - PRELIMINARY NET PRODUCT SALES OF $3.5
MILLION IN Q4, MORE THAN DOUBLE Q3 NET PRODUCT SALES
    * EVOFEM BIOSCIENCES - REDUCED NET CASH BURN RATE TO ABOUT
$17
MILLION IN Q4 OF 2021 VERSUS $32.0 MILLION IN Q3

Source text for Eikon:  ID:nPn8KMj6da 
Further company coverage:  EVFM.O 

 ((reuters.briefs@thomsonreuters.com;))